News
|
|
Cloud Pharmaceuticals CEO to Speak at the AI in Pharma Summit taking place October 17, 2017 in Boston.
Research Triangle Park, NC (Aug. 8, 2017) -- Cloud Pharmaceuticals, a cloud-based drug design and development company, is pleased to announce that company CEO Ed Addison as a speaker at AI in Pharma Summit taking place October17, 2017 in Boston. AI Pharma Summit is An event for the challengers, disruptors and re-thinkers as Machine Learning and Deep Learning transform pharmaceutical R&D
Ed's topic is "Is AI the “Holy Grail” of Drug Discovery?"
Cloud Pharmaceuticals continues to show leadership in the field of artificial intelligence by designing completely novel molecules across the broadest range of targets in the shortest amount of time in this new industry.
For information about the AI Pharma Summit please visit the event site. For information about Cloud Pharmaceuticals or to set up a meeting with a member of our team, please e-mail us.
Research Triangle Park, NC (Aug. 8, 2017) -- Cloud Pharmaceuticals, a cloud-based drug design and development company, is pleased to announce that company CEO Ed Addison as a speaker at AI in Pharma Summit taking place October17, 2017 in Boston. AI Pharma Summit is An event for the challengers, disruptors and re-thinkers as Machine Learning and Deep Learning transform pharmaceutical R&D
Ed's topic is "Is AI the “Holy Grail” of Drug Discovery?"
- Understand where AI can enhance drug discovery and where it cannot, as well as the application of machine learning to ADME/Tox - what works, what doesn't?
- A look at using AI search over novel molecular space - how this is different than virtual screening?
- Machine Learning for discovery -- only as good as the data
- Understand how to combine AI with high fidelity computational chemistry and a look at using AI to reduce computation time for quantum chemistry and FEP
- A look at why docking is of limited utility
- The use of expert systems for medicinal chemistry and synthetic chemistry
Cloud Pharmaceuticals continues to show leadership in the field of artificial intelligence by designing completely novel molecules across the broadest range of targets in the shortest amount of time in this new industry.
For information about the AI Pharma Summit please visit the event site. For information about Cloud Pharmaceuticals or to set up a meeting with a member of our team, please e-mail us.
About Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals is committed to improving health and well-being through the computational design and rapid development of new therapies. Its proprietary Quantum Molecular Design process combines artificial intelligence (AI) and cloud computing to search virtual molecular space and applies along sophisticated molecular modeling to design novel drugs. The process enables faster drug development progress at lower cost and a higher success rate and better targeting of hard-to-drug indications. The company partners at all stages of drug development – from discovery through the clinic – and is building an extensive product pipeline that spans a wide range of indications.
Cloud Pharmaceuticals is committed to improving health and well-being through the computational design and rapid development of new therapies. Its proprietary Quantum Molecular Design process combines artificial intelligence (AI) and cloud computing to search virtual molecular space and applies along sophisticated molecular modeling to design novel drugs. The process enables faster drug development progress at lower cost and a higher success rate and better targeting of hard-to-drug indications. The company partners at all stages of drug development – from discovery through the clinic – and is building an extensive product pipeline that spans a wide range of indications.
###
